Welcome to our dedicated page for Astronova SEC filings (Ticker: ALOT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AstroNova, Inc. filings document an operating company with common stock listed on the Nasdaq Global Market under ALOT. Recent reports include 8-K disclosures for quarterly and annual operating results, amendments to its credit agreement, compensation award terms and other material events tied to its Product Identification and Aerospace businesses.
Proxy and shareholder-meeting filings describe board elections, director nominations, executive compensation votes, auditor ratification and governance matters. The filing record also covers capital structure details such as common stock par value, financial obligations under lending arrangements, exhibit disclosures attached to earnings releases and credit agreement amendments, and formal records related to shareholder proposals and annual meeting procedures.
Kravetz Shawn W reported acquisition or exercise transactions in this Form 4 filing.
AstroNova, Inc. director Shawn W. Kravetz received a grant of 2,760 shares of Common Stock on April 9, 2026. The filing describes this as a restricted stock award under the company’s Amended and Restated Non-Employee Director Annual Compensation Program. Following this award, he directly holds 9,464 shares.
AstroNova Inc ownership disclosure: Dimensional Fund Advisors filed an Amendment No. 12 to Schedule 13G/A reporting beneficial ownership of 435,238 shares of AstroNova Inc common stock, representing 5.7% of the class. The filing shows sole voting power over 430,968 shares and sole dispositive power over 435,238 shares, and states these shares are owned by affiliated Funds for which Dimensional serves as adviser; Dimensional disclaims beneficial ownership. The filing is signed by the Global Chief Compliance Officer on 04/09/2026.
AstroNova, Inc. reported that Senior Vice President Padraig Finn received a grant of 4,590 restricted stock units of AstroNova common stock. This grant was reported as a grant, award, or other acquisition, with no cash price per unit shown in the filing.
Each restricted stock unit represents a contingent right to receive one share of AstroNova common stock. The units are scheduled to vest in three equal annual installments beginning on February 26, 2027, meaning the award will vest over a three-year period as continued service conditions are met.
Carll Thomas Wayne reported acquisition or exercise transactions in this Form 4 filing.
AstroNova, Inc. Senior Vice President Thomas Wayne Carll received a grant of 4,590 restricted stock units on February 26, 2026. Each unit represents the right to receive one share of AstroNova common stock at no purchase price. These units vest in three equal annual installments beginning on February 26, 2027, giving him a time-based incentive to remain with the company and align his compensation with future share performance.
DeByle Thomas D. reported acquisition or exercise transactions in this Form 4 filing.
AstroNova, Inc. reported that Chief Financial Officer Thomas D. DeByle received a grant of 15,483 restricted stock units. Each unit represents the right to receive one share of ALOT common stock. The units vest in three equal annual installments beginning on February 26, 2027.
AstroNova, Inc. reported that Chief Executive Officer Jorik Ittmann acquired 13,115 restricted stock units as an equity award. Each unit represents a contingent right to receive one share of AstroNova common stock. The units vest in three equal annual installments beginning on February 26, 2027, aligning the CEO’s compensation with future company performance.
Natalizia Michael J reported acquisition or exercise transactions in this Form 4 filing.
AstroNova, Inc. reported that Chief Technology Officer Michael J. Natalizia received a grant of 4,590 restricted stock units on February 26, 2026. Each unit represents a right to one share of AstroNova common stock and vests in three equal annual installments starting February 26, 2027.
AstroNova, Inc. reported the results of its annual shareholder meeting held on December 2, 2025. A total of 7,638,423 shares of common stock were outstanding as of October 13, 2025, the record date for the meeting.
Shareholders elected seven directors to serve until the next annual meeting and until their successors are elected and qualified. They also approved an advisory, non-binding proposal on the compensation paid to the company's executive officers, with 4,485,855 votes for, 34,705 against, 3,905 abstentions and 2,549,495 broker non-votes. In a separate advisory vote on how often to hold future say-on-pay votes, 4,089,313 votes favored a 1-year frequency, 3,518 favored 2 years, 431,387 favored 3 years, and 248 abstained, with 2,549,494 broker non-votes. Shareholders further ratified the appointment of Wolf & Company, P.C. as independent registered public accounting firm for the fiscal year ending January 31, 2026, by a vote of 7,064,130 for, 6,440 against and 3,390 abstaining.
AstroNova (ALOT) amended its credit agreement with Bank of America. The change raises the revolving commitment to $27,500,000 until July 31, 2026 (then $25,000,000), extends the revolver maturity to August 4, 2028, and refinances prior term debt into a new $10,000,000 Term Loan and a new $9,720,000 Term A-2 Loan. At closing, the company borrowed both term loans and $1,500,000 on the revolver; proceeds were used primarily to repay and refinance existing term loans and pay related costs. The facility remains available for general corporate purposes. The company currently has $17.9 million drawn on the amended revolver.
Repayment terms include quarterly $500,000 installments on the Term Loan through July 31, 2028 with the balance due August 4, 2028, and monthly $40,500 installments on the Term A-2 Loan through July 31, 2035 with the balance due August 4, 2035. Borrowings bear interest at Term SOFR or a floating base rate plus margins of 1.60%–3.25% (or 0.60%–2.25% for base rate), and a commitment fee of 0.15%–0.40% applies to undrawn revolver amounts. Multi‑currency options remain, along with customary covenants and collateral, and the amendment removes the minimum consolidated interim fixed charge coverage ratio.